MKS (MKSI) is a Technology company in the Scientific Technical Instruments industry. It has a market capitalization of $13.00B, a trailing price-to-earnings ratio of 15.7 and a free-cash-flow yield of 3.8%. Over the most recent reported fiscal year, revenue grew 9.6% and free cash flow per share grew 21.0%. Nama's AI scorecard rates it Buy, 6.6 out of 10. On 12-month momentum it ranks in the leading band of its market.
AI scorecard
Buy · 6.6/10
Positive, at the low end of Buy. As of Nov 7, 2026.
Momentum
Leading · +76.0% over 12 months ex. last
Top 20% of its market on the past year's steady rise.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-57.0%
How far the last close sits under the highest price of the past five years.
Market cap
$13.00B
Trailing P/E
15.7
Price / book
4.3
Price / sales
3.0
FCF yield
3.8%
Dividend yield
0.5%
Gross margin
47.0%
Operating margin
16.7%
Net margin
10.1%
Revenue growth (YoY)
+9.6%
Revenue growth (3-yr annual)
+3.5%
EPS growth (YoY)
+19.8%
FCF/share growth (YoY)
+21.0%
Beta
2.0
Exchange
NASDAQ
Sector
Technology
Industry
Scientific Technical Instruments
MKSI earnings
Next report: Feb 16, 2027 (Q4 2026, EPS estimate $3.95).
Beat the EPS estimate in 4 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Nov 4, 2026
$4.18
$3.65
+14.5%
$1.41B
Q2 2026
Aug 5, 2026
$3.30
$2.96
+11.5%
$1.25B
Q1 2026
May 6, 2026
$2.30
$2.05
+12.2%
$1.08B
Q4 2025
Feb 17, 2026
$2.47
$2.46
+0.4%
$1.03B
MKSI analyst price target
Median target $405.00 from 14 analysts, ranging $270.00 – $600.00.
Nama's AI scorecard currently rates MKS Buy (6.6 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is MKSI's P/E ratio?
MKS trades at a trailing price-to-earnings ratio of 15.7.
When does MKSI report earnings?
MKS's next scheduled report is on Feb 16, 2027. Analysts expect EPS of $3.95.
What is the MKSI price target?
The median analyst price target from 14 analysts is $405.00, with a range of $270.00 – $600.00.
Is MKSI Shariah compliant?
Nama's AAOIFI-style screen reads MKS as Not Shariah Compliant. At least one of the three ratios or the industry test failed.